Related Experiment Video

Updated: Mar 12, 2026

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
06:48

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells

Published on: June 16, 2022

2.5K

MicroRNA-146a Contributes to SCI Recovery via Regulating TRAF6 and IRAK1 Expression

Jinsong Wei1, Jiafeng Wang2, Yulan Zhou2

  • 1Department of Orthopedics, The First Affiliated Hospital of Jinan University, Guangzhou, China.

Biomed Research International
|November 11, 2016
PubMed

Insights

MicroRNA-146a plays a role in spinal cord injury (SCI) recovery by inhibiting inflammation. This study shows miRNA-146a suppresses IRAK1 and TRAF6, suggesting it

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Spinal cord injury (SCI) is a debilitating condition with limited therapeutic options.
  • MicroRNA-146a (miRNA-146a) has been implicated in inflammatory responses, but its specific role in SCI recovery was unclear.
  • Understanding the molecular mechanisms underlying SCI is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of miRNA-146a in the recovery process following spinal cord injury.
  • To elucidate the molecular targets and pathways regulated by miRNA-146a in the context of SCI.
  • To evaluate miRNA-146a as a potential therapeutic target for SCI.

Main Methods:

  • Establishment of a rat model for spinal cord injury.
  • Measurement of miRNA-146a target gene expression (IRAK1, TRAF6) and pro-inflammatory cytokines post-SCI.
  • Assessment of motor function recovery using the Basso Beattie Bresnahan (BBB) scale.
  • Luciferase assay to confirm direct targeting of IRAK1 and TRAF6 mRNAs by miRNA-146a.

Main Results:

  • miRNA-146a directly targets the mRNAs of IRAK1 and TRAF6.
  • miRNA-146a suppresses the expression of IRAK1, TRAF6, and pro-inflammatory cytokines in the SCI model.
  • Administration of a miRNA-146a antagomir affected SCI recovery and inflammatory markers.
  • The IRAK1/TRAF6 pathway may upregulate miRNA-146a in response to inflammatory mediators in the spinal cord.

Conclusions:

  • miRNA-146a acts as a negative feedback regulator, controlling IRAK1 and TRAF6 expression in SCI.
  • The miRNA-146a/IRAK1/TRAF6 axis plays a significant role in modulating inflammation after spinal cord injury.
  • miRNA-146a represents a promising novel therapeutic target for interventions aimed at improving SCI recovery.

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

8.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K